Objectives: To investigate the cholesterol efflux capacity of the in vitro EL-modified human- and in vivo EL-modified mouse-serum, -apoB-depleted serum and -HDL.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
EAS16-0118 Experimental Cadiovascular Medicine I
Identification
Copyright
© 2016 Published by Elsevier Inc.
